Individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) had a higher rate of appearance of oral glucose — particularly during the first hour after a glucose load — and higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback